FR2517967A1 - Procede de production d'un vaccin biochimique contre les fievres a salmonelles - Google Patents
Procede de production d'un vaccin biochimique contre les fievres a salmonelles Download PDFInfo
- Publication number
- FR2517967A1 FR2517967A1 FR8123067A FR8123067A FR2517967A1 FR 2517967 A1 FR2517967 A1 FR 2517967A1 FR 8123067 A FR8123067 A FR 8123067A FR 8123067 A FR8123067 A FR 8123067A FR 2517967 A1 FR2517967 A1 FR 2517967A1
- Authority
- FR
- France
- Prior art keywords
- salmonella
- vaccinating
- vaccine against
- fevers
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000607142 Salmonella Species 0.000 title claims abstract description 17
- 229960005486 vaccine Drugs 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 12
- 239000000427 antigen Substances 0.000 claims abstract description 18
- 108091007433 antigens Proteins 0.000 claims abstract description 18
- 102000036639 antigens Human genes 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 18
- 206010037660 Pyrexia Diseases 0.000 claims abstract description 13
- 239000012528 membrane Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 230000001580 bacterial effect Effects 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 241001465754 Metazoa Species 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 238000000746 purification Methods 0.000 claims abstract description 4
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 3
- 238000004108 freeze drying Methods 0.000 claims abstract 2
- 230000000890 antigenic effect Effects 0.000 claims description 9
- 239000008188 pellet Substances 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000010908 decantation Methods 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- -1 polyoxyethylenes Polymers 0.000 claims description 3
- 238000002255 vaccination Methods 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 238000005194 fractionation Methods 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 238000000464 low-speed centrifugation Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 claims 1
- 230000029219 regulation of pH Effects 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 abstract description 3
- 229960001212 bacterial vaccine Drugs 0.000 abstract 1
- 201000008297 typhoid fever Diseases 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940126578 oral vaccine Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/879—Salmonella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8123067A FR2517967A1 (fr) | 1981-12-10 | 1981-12-10 | Procede de production d'un vaccin biochimique contre les fievres a salmonelles |
| US06/447,503 US4503036A (en) | 1981-12-10 | 1982-12-07 | Process for producing a biochemical vaccine against Salmonella infection |
| AT82402249T ATE14984T1 (de) | 1981-12-10 | 1982-12-09 | Verfahren zur herstellung eines biochemischen vakzins gegen salmonellenfieber. |
| DE8282402249T DE3265664D1 (en) | 1981-12-10 | 1982-12-09 | Process for the production of a biochemical vaccine against salmonella fevers |
| CA000417371A CA1176166A (fr) | 1981-12-10 | 1982-12-09 | Procede de production d'un vaccin biochimique contre les fievres a salmonelles |
| EP82402249A EP0082072B1 (fr) | 1981-12-10 | 1982-12-09 | Procédé de production d'un vaccin biochimique contre les fièvres à salmonelles |
| JP57215645A JPS58109426A (ja) | 1981-12-10 | 1982-12-10 | サルモネラ菌による感染に対して有効な細菌ワクチンの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8123067A FR2517967A1 (fr) | 1981-12-10 | 1981-12-10 | Procede de production d'un vaccin biochimique contre les fievres a salmonelles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2517967A1 true FR2517967A1 (fr) | 1983-06-17 |
| FR2517967B1 FR2517967B1 (enExample) | 1984-12-07 |
Family
ID=9264860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8123067A Granted FR2517967A1 (fr) | 1981-12-10 | 1981-12-10 | Procede de production d'un vaccin biochimique contre les fievres a salmonelles |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4503036A (enExample) |
| EP (1) | EP0082072B1 (enExample) |
| JP (1) | JPS58109426A (enExample) |
| AT (1) | ATE14984T1 (enExample) |
| CA (1) | CA1176166A (enExample) |
| DE (1) | DE3265664D1 (enExample) |
| FR (1) | FR2517967A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981685A (en) * | 1986-03-07 | 1991-01-01 | Utah State University Foundation | Bacterial extract vaccines for veterinary application |
| US5554372A (en) * | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| EP0283505B1 (en) * | 1986-09-22 | 1994-07-06 | Emory University | Vaccine and method of preparation |
| WO1992007934A1 (en) * | 1990-11-01 | 1992-05-14 | Iowa State University Research Foundation, Inc. | Bacterial attenuation method and vaccine |
| US5580557A (en) * | 1991-10-09 | 1996-12-03 | Iowa State University Research Foundation, Inc. | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals |
| US6254874B1 (en) | 1995-04-13 | 2001-07-03 | President And Fellows Of Harvard College | Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
| US6605285B2 (en) | 2000-03-29 | 2003-08-12 | G.B. Pant University Of Agriculture & Technology | Vaccine for protection of poultry against salmonellosis and a process for preparing the same |
-
1981
- 1981-12-10 FR FR8123067A patent/FR2517967A1/fr active Granted
-
1982
- 1982-12-07 US US06/447,503 patent/US4503036A/en not_active Expired - Fee Related
- 1982-12-09 DE DE8282402249T patent/DE3265664D1/de not_active Expired
- 1982-12-09 CA CA000417371A patent/CA1176166A/fr not_active Expired
- 1982-12-09 AT AT82402249T patent/ATE14984T1/de not_active IP Right Cessation
- 1982-12-09 EP EP82402249A patent/EP0082072B1/fr not_active Expired
- 1982-12-10 JP JP57215645A patent/JPS58109426A/ja active Pending
Non-Patent Citations (6)
| Title |
|---|
| CA1979 * |
| CA1982 * |
| EXBK/77 * |
| EXBK/78 * |
| EXBK/80 * |
| EXBK/82 * |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2517967B1 (enExample) | 1984-12-07 |
| DE3265664D1 (en) | 1985-09-26 |
| US4503036A (en) | 1985-03-05 |
| JPS58109426A (ja) | 1983-06-29 |
| EP0082072A1 (fr) | 1983-06-22 |
| EP0082072B1 (fr) | 1985-08-21 |
| ATE14984T1 (de) | 1985-09-15 |
| CA1176166A (fr) | 1984-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2332587T3 (es) | Cultivo de lawsonia intracellularis, vacunas anti-lawsonia intracellularis y agentes de diagnostico. | |
| Hackstadt et al. | Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity | |
| US6019982A (en) | Mutant enterotoxin effective as a non-toxic oral adjuvant | |
| FR2475900A1 (fr) | Complexe vaccinal contenant un antigene specifique et vaccin le contenant | |
| EP0024493A2 (en) | Multivalent pneumococcal vaccine | |
| Amend et al. | Some factors affecting the potency of Yersinia ruckeri bacterins | |
| EP0082072B1 (fr) | Procédé de production d'un vaccin biochimique contre les fièvres à salmonelles | |
| EP0179679A1 (fr) | Polysaccharides membranaires utiles notamment comme médicament et procédé pour leur préparation | |
| WO2023225458A1 (en) | Vaccines against moritella viscosa | |
| CH662056A5 (fr) | Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies. | |
| JP3399525B2 (ja) | ボルデテラに対するワクチンとしてのアデニルシクラーゼ又はアデニルシクラーゼ産生細菌の使用 | |
| US4857318A (en) | Bordetella bronchiseptica pilus subunit protein vaccine effective against bordetella pertussis | |
| EP1158993B1 (fr) | Fractions membranaires bacteriennes a effet adjuvant | |
| Mukkur et al. | Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and calves | |
| Basak et al. | Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens | |
| JP2965046B2 (ja) | ブタ赤痢用の減少化タンパク質のサブユニットワクチン | |
| LU87809A1 (fr) | Exopolymere extracellulaire,son procede de preparation et compositions pharmaceutiques le contenant | |
| EP0420743B1 (fr) | Vaccin protecteur contre l'hémophilose porcine | |
| CN115261290B (zh) | 一种具有免疫调节功能的戊糖片球菌菌株及其应用 | |
| CN111712256A (zh) | 单价疫苗制剂及其制备方法 | |
| Salih et al. | Vaccination of cattle with Mycoplasma bovoculi antigens: evidence for field immunity | |
| FR2571618A1 (fr) | Nouveau vaccin contre la tracheobronchite infectieuse canine et son procede de preparation | |
| FR2524315A1 (fr) | Nouvel antigene pour la recherche de l'hypersensibilite cutanee brucellique notamment chez l'homme, et son procede de preparation | |
| CA3187934A1 (en) | Lyophilized live bordetella vaccines | |
| FR2517966A1 (fr) | Procede de production d'un vaccin biochimique anti-pesteux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |